July 13, 2018
Insulet Corp. shareholders have agreed to take an undisclosed settlement that includes $425,000 for attorneys in exchange for dropping allegations that executives at the insulin pump manufacturer manipulated sales numbers, the investors told a Massachusetts federal judge on Friday.